incretin hormone is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-03. Numbers and descriptions here follow the published literature rather than marketing material.
Lyophilised material appears as a white to off-white cake or powder that is hygroscopic, and containers are usually equilibrated to room temperature before opening to limit condensation. Dissolution is performed in water, phosphate-buffered saline, or a mildly alkaline buffer, since solubility rises above neutral pH. Gentle inversion or low-speed mixing is preferred, because vigorous vortexing can promote surface denaturation and aggregation. Complete dissolution may require several minutes, and brief sonication is sometimes applied. Passing the solution through a 0.22 micrometre membrane removes particulates but does not by itself sterilise the liquid.
Storage at minus 20 degrees Celsius or lower in a desiccated container preserves the peptide for extended periods, while working solutions are commonly held at two to eight degrees Celsius for short intervals. Light exposure and repeated freeze-thaw cycles accelerate degradation, so dividing material into single-use aliquots is generally recommended. Adsorption to glass and plastic surfaces can lower the measured concentration of dilute solutions, particularly below one milligram per millilitre. The degradation routes most often reported for GLP-1 analogues are deamidation, methionine oxidation, and backbone hydrolysis. Relative rates under specific conditions are frequently described only for individual formulations.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | RP-HPLC, 214 nm | Wavelength affects relative peak areas |
| Identity confirmation | LC-MS/MS | Precursor and fragment ion masses compared |
| Common degradation | Deamidation, oxidation | Amide and methionine residues are main sites |
| Working solution storage | 2-8 °C, short term | Longer holding favours frozen aliquots |
| Adsorption risk | Higher below 1 mg/mL | Glass and plastic surfaces both affected |
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
Semaglutide dissolves readily in water and in aqueous buffers near neutral pH. Solubility decreases near the isoelectric point, where net charge is minimal. Common laboratory solvents include phosphate-buffered saline and dilute ammonium bicarbonate. Strongly acidic or basic conditions may accelerate hydrolysis. Working concentrations are usually prepared by diluting a concentrated stock. Vial surfaces can adsorb small amounts of peptide at low concentrations, so carrier proteins or low-binding tubes are sometimes used.
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
On March 19, 2012, UPS announced that it intended to acquire TNT Express for $6.8 billion, in a move to help expand its presence in European and Asian markets. However, the deal fell through in January 2013, after it was announced that UPS had failed to obtain permission from the European Commission and as such had been blocked on competition grounds. In February 2012, UPS acquired Brussels-based company Kiala that provides e-commerce retailers the option to have goods delivered to a conventional retail location. In 2018, The Wall Street Journal reported that UPS's operations were hampered by its outdated 20th-century technology, lagging behind its competitors. In May 2019, UPS launched a partnership with autonomous trucking startup TuSimple to carry cargo across Phoenix, Arizona, and Tucson, Arizona. In October 2019, UPS won the approval of the Federal Aviation Administration to fly drones. The certification will allow UPS to deliver health care supplies using a fleet of drones. On January 29, 2020, UPS announced it was investing in UK start-up Arrival and ordering 10,000 Generation 2 electric vehicles as a step towards a cleaner, more high-tech fleet. The deal ran from 2020 until 2024 and was reported to be worth more than $400 million. In March 2020, the company appointed Carol Tomé to succeed David Abney as its chief executive officer. It was viewed as a move to steer the parcel delivery company through the turbulence of trade wars, technological disruption and the risk of a pandemic-induced recession.
The number of people living in urban areas grew by 31.2% between 1991 and 2001. In 2001, over 70% lived in rural areas. The level of urbanisation increased further from 27.81% in the 2001 census to 31.16% in the 2011 census. The overall population growth rate slowed because rural growth declined sharply after 1991. In the 2011 census, there were 53 million-plus urban agglomerations in India, among them Mumbai, Delhi, Kolkata, Chennai, Bangalore, Hyderabad and Ahmedabad, in decreasing order by population.
== Medical and science == Computational Science, an academical research discipline Canadian Light Source, a synchrotron light source Clinical laboratory science, another name for Medical Technology or Medical Laboratory Science Combat lifesaver, US non-medical military role
=== Prout's hypothesis and the whole number rule === The whole number rule states that the masses of the isotopes are integer multiples of the mass of the hydrogen atom. The rule is a modified version of Prout's hypothesis proposed in 1815, to the effect that atomic weights are multiples of the weight of the hydrogen atom.
Sources: en.wikipedia.org
May 13 – COVID-19 pandemic – The Centers for Disease Control and Prevention states that all "fully vaccinated people can resume activities without wearing a mask or physically distancing, except where required by federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance". May 14 Colonial Pipeline operations return to normal late in the day, but gas outages at retail stations will take several days to clear. Tennessee Gov. Bill Lee signs public school "bathroom bill", HB1233, into law. The bill specifies that schools must comply to reasonable requests made by students and staff to provide them with access to a reasonably private bathroom that is restricted to occupants of their same sex. May 17 Former Matt Gaetz associate Joel Greenberg pleads guilty to six charges of sex trafficking. The U.S. Supreme Court agrees to take up Dobbs v. Jackson Women's Health Organization, a Mississippi case on abortion rights. May 18 – The U.S. Preventive Services Task Force lowers the age to begin routine screenings for colorectal cancer from 50 to 45. May 24 COVID-19 pandemic The State Department tells Americans not to travel to Japan due to a spike in COVID-19 cases there. Delaware reports their first case of the Lineage B.1.617 variant that originated in India. A suspicious package is sent to the home of U.S. Senator Rand Paul (R–KY). The incident is being investigated by the Federal Bureau of Investigation and United States Capitol Police.
Control of pH, which affects the ionization state of the ionizable analytes. Affect the charge upon ionizable parts of the surface of the stationary phase. For example, the silica surface in between the bonded phase ligands is usually covered with silanol groups that can deprotonate. Act as ion pairing agents to neutralize analyte charge. If mass spectrometry is used to analyze the eluate, then a volatile organic acid often added to the eluent such as acetic acid or formic acid. Ammonium formate is commonly added to improve detection of certain analytes by the formation of analyte-ammonium adducts, which are more volatile than the analytes themselves. Trifluoroacetic acid (TFA) as additive to the mobile phase is widely used for complex mixtures of biomedical samples, mostly peptides and proteins, using mostly UV based detectors. TFA also increases retention of analytes such as carboxylic acids, in applications utilizing other detectors (such as UV-VIS), as it is a fairly strong organic acid. However, they are rarely used in mass spectrometry methods, due to residues it can leave in the detector and solvent delivery system, which interfere with the analysis and detection. The silica particles in reverse-phase are less likely to be damaged compared to silica particles in normal-phase, since they are shielded by surface-bonded hydrophobic ligands. However, most reversed phase columns consist of alkyl derivatized silica particles, and are prone to hydrolysis of the silica at acidic conditions (pH < 2). Also, silica itself dissolves at alkaline onditions (pH > 8).
"APS user shares the "Israeli Nobel" for chemistry", from the Argonne National Laboratory Advanced Photon Source (APS), United States Department of Energy The Official Site of Louisa Gross Horwitz Prize Weizmann Institute of Science, Yonath-Site Talk by Ada Yonath at the Origins 2011 congress Ada E. Yonath on Nobelprize.org Ada Yonath at IMDb
Sources: en.wikipedia.org
=== Canada patent lawsuit === In September 2013, Eli Lilly sued Canada for violating its obligations to foreign investors under the North American Free Trade Agreement by allowing its courts to invalidate patents for Atomoxetine (Strattera) and Olanzapine (Zyprexa). Canadian courts found the seven-week long study of 22 patients for Atomoxetine (Strattera), too short and too narrow in scope to qualify for the patent. The Olanzapine (Zyprexa) patent was invalidated because it had not achieved its promised utility. The company sought damages in the amount of $500 million for lost profits. They ultimately lost the case in 2017.
== Further reading == Gessel, Van C. Three Modern Novelists: Sōseki, Tanizaki, Kawabata. New York: Kodansha International, 1993. Ito, Ken Kenneth. Visions of Desire: Tanizaki’s Fictional Worlds. Stanford: Stanford University Press, 1991. Keene, Donald. Dawn to the West: Japanese Literature of the Modern Era. New York: Hold, Rinehart, and Winston, 1984. Pollack, David. Reading Against Culture: Ideology and Narrative in the Japanese Novel. Ithaca: Cornell University Press, 1992.
=== Resistance === Three mechanisms of resistance to chloramphenicol are known: reduced membrane permeability, mutation of the 50S ribosomal subunit, and elaboration of chloramphenicol acetyltransferase. It is easy to select for reduced membrane permeability to chloramphenicol in vitro by serial passage of bacteria, and this is the most common mechanism of low-level chloramphenicol resistance. High-level resistance is conferred by the cat-gene; this gene codes for an enzyme called chloramphenicol acetyltransferase, which inactivates chloramphenicol by covalently linking one or two acetyl groups, derived from acetyl-S-coenzyme A, to the hydroxyl groups on the chloramphenicol molecule. The acetylation prevents chloramphenicol from binding to the ribosome. Resistance-conferring mutations of the 50S ribosomal subunit are rare. Chloramphenicol resistance may be carried on a plasmid that also codes for resistance to other drugs. One example is the ACCoT plasmid (A=ampicillin, C=chloramphenicol, Co=co-trimoxazole, T=tetracycline), which mediates multiple drug resistance in typhoid (also called R factors). As of 2014 some Enterococcus faecium and Pseudomonas aeruginosa strains are resistant to chloramphenicol. Some Veillonella spp. and Staphylococcus capitis strains have also developed resistance to chloramphenicol to varying degrees. Some other resistance genes beyond cat are known, such as chloramphenicol hydrolase, and chloramphenicol phosphotransferase.
Sources: en.wikipedia.org
Filtering removes particulate matter that can block columns or scatter light. A 0.22 micrometre membrane is typical, and the filter material should be checked for peptide adsorption.
Peptides can bind to glass and plastic, so a fraction of the material leaves the solution. The effect is proportionally larger in dilute samples and can bias quantitative results.
Reverse-phase high-performance liquid chromatography is the most widely reported approach. Purity figures should always be quoted together with the wavelength, gradient, and integration parameters used.
It is a glucagon-like peptide-1 receptor agonist, often grouped with the incretin mimetics. Its backbone is modified from the human hormone to resist enzymatic degradation and to bind albumin. These two features distinguish it from the native peptide.